ABSTRACT
V iral hemorrhagic septicemia virus (VHSV) is an enveloped, nonsegmented negative-sense (NNS), single-stranded RNA virus that belongs to the Novirhabdovirus genus of the family Rhabdoviridae (1) . The virus genome contains the nucleocapsid (N) protein, polymerase-associated phosphoprotein (P), matrix (M) protein, surface glycoprotein (G), and viral polymerase (L) genes and a nonstructural (NV) protein gene (1) . Until the late 1980s, VHSV was thought to cause only a disease of farmed rainbow trout (Oncorhynchus mykiss) in Europe, but with the detection of VHSV in returning Chinook (2) and Coho (3) salmon in the United States, later defined as genotype IVa, its detection in Atlantic cod (Gadus morhua) (4) , and later the identification of a VHSV (genotypes I to III) in a vast number of marine fish species in Europe (5) , the understanding of the virus's origin, its species range, and the dynamics of the interchange between wild and farmed populations changed. Investigations into the source of the trout-pathogenic European genotype Ia isolate showed that it likely emerged from a marine source some 60 years earlier (6) . Today, VHSV is separated into four different genotypes (I to IV) with different sublineages (6, 7) , and the different genotypes are separated geographically. All European marine VHSV strains have been shown to be nonpathogenic or have very low pathogenicity to rainbow trout after a waterborne challenge (5, 6, 8) . The marine source of genotype I (6-11) and the later emergence of a troutvirulent genotype III isolate of marine origin in Norway (12) show that VHSV is capable of crossing host species barriers. Obviously, this creates a continuous concern to aquaculture operations, but it has not been possible to link virulence traits to specific sequence motifs of any of the expressed virus proteins. One approach has been to identify pathogenicity markers of these new variants through genome sequencing (10, 13) , but so far it has not been possible to tie such variation or specific amino acid motifs of the viral proteins to virulence (14) . We have shown that the ability of defined VHSV strains to infect and translocate across primary cultures of rainbow trout gill epithelial cells (GECs) correlate with in vivo virulence by using a bath challenge of trout fry (15) . Isolates not able to infect (flat) cultures of GECs and/or translocate across polarized GECs also did not cause death postchallenge. In this study, we obtained the same results and found that one genotype Ia isolate (6) and a genotype III (NO/650/07) variant (12) , both pathogenic to trout (by in vivo challenge), are able to infect and translocate across GECs. In contrast, two marine strains nonpathogenic to trout, genotype Ib strain 1p8 (16) and genotype IVa strain JF-09, lack the ability to infect, replicate in, and translocate across GECs cultures in vitro. Thus, we found that the in vitro GEC infection model is a good proxy of in vivo virulence to trout. All four isolates were sequenced and aligned, and we selected eight conserved amino acid substitutions contrasting high-and lowvirulence strains. Reverse genetics was used and the JF-09 backbone was point mutated at the selected residues to obtain seven different mutant JF-09 virus clones (all able to replicate in epithelioma papulosum cyprini [EPC] cells). Through this gain-of-virulence approach, we show for the first time that the replacement of a single amino acid of the L protein, isoleucine (I) at position 1012, which is in conserved region IV (CRIV), with phenylalanine (F) renders mutant JF-09 able infect, replicate in, and induce a cytopathic effect (CPE) in trout GECs. The other mutated variants of JF-09 were nonpathogenic, like wild-type (WT) JF-09.
MATERIALS AND METHODS

Cells and viruses.
VHSV isolates designated DK-3592B (genotype Ia), 1p8 (genotype Ib), NO/650/07 (genotype III), and JF-09 (genotype IVa) were used in this study and propagated in EPC cells (ATCC CRL-2872) in L15 cell medium (Invitrogen) containing 10% fetal bovine serum (FBS; Sigma-Aldrich) at 15°C (15) . Strains DK-3592B and 1p8 were a kind gift of Niels Jørgen Olesen, Danish Veterinary Institute, Århus, Denmark, and NO/650/07 was kindly provided by Renate Johansen, Norwegian Veterinary Institute, Oslo, Norway. Isolate JF-09 originated from VHSV-infected olive flounder (Paralichthys olivaceus) in South Korea. All strains were plaque purified and propagated in EPC cells in L15 cell medium (Invitrogen) containing 10% FBS (Sigma-Aldrich) at 15°C. Titration was performed on EPC cells by the 50% tissue culture infective dose (TCID 50 ) method as described previously (17) . In addition, we used primary cultured rainbow trout GECs isolated from fry of rainbow trout (18, 19) as modified by Brudeseth et al. (15) .
Complete genomic sequencing of strain JF-09. Gene-specific primers (GSPs) for sequencing were designed to produce overlapping fragments (Table 1) . First-strand cDNA synthesis was carried out with the Transcriptor First Strand cDNA synthesis kit (Roche). Reverse transcription (RT)-PCR was done with a thermal cycler with denaturation at 98°C for 10 s, annealing at 60°C for 30 s, and extension at 72°C for 1 min. In order to identify the 3=-terminal region of the genomic RNA, a poly(A) tail was added to the 3= end by using the poly(A) polymerase enzyme with the mMESSAGE mMACHINE T7 Ultra kit (Ambion), and RNA was purified with the RNeasy Plus minikit (Qiagen). cDNA synthesis was conducted with a SMARTer rapid amplification of 5= cDNA ends (RACE) cDNA Amplification kit (Clontech) with a VHSV-f1-Reverse GSP ( Table 1) . The 5=-terminal region of genomic RNA was identified by RACE with a JF09 5= end (5=-CCTCGGTGCCCTGCTCCACCTGGAGTCC-3=) GSP and a SMARTer RACE cDNA amplification kit (Clontech). The amplified cDNAs of 3= and 5= ends were cloned with a TOPO TA Cloning kit (Invitrogen). The 3= and 5= RACE and RT-PCR products were sequenced by GATC Biotech, Germany. The assembly of contiguous sequences, multiple-sequence alignments, and comparative sequence analyses were conducted with Vector NTI Advance 11 software (Invitrogen) and BLAST searches of the NCBI database.
Plasmid constructions. The complete genomic plasmid was constructed by assembling two overlapping subclones in modified pTurboFP635-N vectors (Evrogen) with GSPs ( Table 2 ). In the final construct, the trailer end of antigenome cDNA was fused with hepatitis delta virus ribozyme (HdvRz) (20) , followed by the simian virus 40 early mRNA polyadenylation signal. For construction of helper plasmids, RT-PCR was used to amplify the open reading frames (ORFs) of the N, P, L, and NV 
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genes with GSPs ( Table 2) . A Kozak consensus sequence was created in front of the start codon of each ORF. The amplified genes were cloned into modified pTurboFP635-N vectors and were under the control of the cytomegalovirus promoter. The recombinant JF-09 (rJF-09) isolate was rescued from EPC cells transfected with VHSV plasmids and helpers with FuGENE HD transfection reagent (Roche) as described previously (21).
In vitro replication of VHSV in rainbow trout GECs. For immunofluorescence staining (IFAT), GECs (1 ϫ 10 6 ) were seeded into 24-well plates and cultured for 24 h at 20°C (15) . The cells were infected with VHSV isolates (multiplicity of infection [MOI] of 10) and further incubated at 15°C. Sampling was performed at the time points indicated (see below) by fixing the cells in a 4% paraformaldehyde solution for 20 min. VHSV was identified by IFAT with monoclonal antibody (MAb) IP5B11 (anti-N protein) (15) as the primary antibody. Anti-rainbow trout Mx antibody was used to detect Mx protein in infected cells (22) . Stained cells were washed and examined with an inverted Olympus IX81 fluorescence microscope.
Virus replication in GECs (1 ϫ 10 5 ) was assessed by quantitative realtime RT-PCR. Every 24 h, 100 l cell culture supernatant was sampled for RNA extraction with a viral RNA minikit (Qiagen) and cDNAs were synthesized with a Transcriptor First Strand cDNA synthesis kit (Roche). Quantitative RT-PCR was carried out with a LightCycler 480 SYBR green I master mix and the LightCycler 480 system (Roche) with a pair of GSPs (0.5 M), VHSV 23-N-Forward (5=-CGCCATCATGATGAGTCGGATG CTG-3=) and VHSV 23-N-Reverse (5=-CTTCTCTGTCACCTTGATCCC CTCC-3=), targeting a conserved N protein gene in four VHSV isolates. The specificity of the PCR products was confirmed by melting curve analysis and subsequent agarose gel electrophoresis.
For viability analysis, GECs (6.4 ϫ 10 4 ) were seeded into 96-well plates and cultured for 24 h at 20°C. Three different virus preparations (MOIs of 0.15, 1.5, and 15) of each of the four VHSV isolates were added to the cell cultures. Cell viability was measured with a CellTiter AQ ueous One solution reagent (Promega) (15) .
Transepithelial passage through GECs. An in vitro system was set up to determine the ability of VHSV to translocate across the barrier of GECs (15, 24) . GECs (2.5 ϫ 10 5 ) were seeded onto insert filters (Falcon; 0.4-m pore size). Infection (MOI of 0.4) of cells was initiated when the transepithelial electrical resistance (TER) exceeded 1.0 ϫ 10 3 ⍀/cm 2 (15) . Transepithelial passage of virus to the bottom well was detected by inoculation onto EPC cells, assessment of a CPE, and detection by IFAT (15) .
In vivo virulence of WT JF-09 in rainbow trout. Strains DK-3592B, 1p8, and NO/650/07 had all been tested for in vivo virulence in rainbow trout and shown to be pathogenic (DK-3592B [15] and NO/650/07 [12] ) or nonpathogenic (1p8 [15] ). The in vivo pathogenicity of WT JF-09 to rainbow trout and olive flounder was tested by using artificial infection. Olive flounder (20 Ϯ 2 g) were divided into three groups kept in tanks containing 20 liters of UV-disinfected seawater at 11 Ϯ 0.5°C in a controlled indoor seawater facility. The fish were acclimatized to their respective rearing conditions for 7 days prior to infection. Ten fish per group were injected intramuscularly (i.m.) with 100 l of a viral suspension (10 6.5 or 10 5.5 TCID 50 per fish), and six fish were given phosphate-buffered saline (PBS) as a control. The rainbow trout infection trial was carried out in triplicate tanks by immersion and intraperitoneal (i.p.) injection (average weight, 2.0 g). Two tanks were infected by immersion with DK-3592B as a positive control, and two tanks (per administration) of fish treated by virus-free cell medium immersion and injected to simulate stress conditions served as noninfected negative controls. Immersion infection was carried out for 2 h with 8 liters of softened tap water with a viral suspension added. The challenge dose of WT JF-09 was 10 4.5 TCID 50 /ml of water, and that of DK-3592B was 10 3.7 TCID 50 /ml of water. WT JF-09 was also injected i.p. at 10 5.5 TCID 50 per fish under anesthesia (benzocaine, 10 mg/liter). Approximately 35 fish were placed into each tank. During the infection trials, fish were kept in tanks containing 8 liters of soft, fresh, unchlorinated water (around 3 German degrees [dH]) maintained at 10.5 Ϯ 1.1°C. Fish that died during the experiment were sampled for virus examination. Deaths were recorded daily.
Sequencing of ORFs and amino acid comparison analysis. ORF sequences were obtained by first-strand cDNA synthesis with the Transcriptor First Strand cDNA synthesis kit (Roche) with extracted total RNAs according to the manufacturer's instructions. Consensus GSP sets (Table  1) were used for complete genomic sequences (by GATC Biotech) from cDNAs of four VHSV isolates (DK-3952B, 1p8, NO/650/07, and JF-09). The assembly of contiguous sequences, multiple-sequence alignments, and comparative sequence analyses were conducted with Vector NTI Advance 11 software (Invitrogen).
Mutated variants of JF-09. Site-directed mutagenesis (GENEART site-directed mutagenesis system; Invitrogen) with GSPs (Table 3) was performed, and seven different variants were generated, T288 G A, VSE55-57 NV ILD, E57 NV D, G80 NV R, G149 L E, E298 L K, and I1012 L F (see Fig. 4B ). Mutated plasmids pVHSV JF-09 (120 ng), pN (70 ng), pP (30 ng), pNV (15 ng), and pL (30 ng) were mixed into 25 l Opti-MEM medium (Invitrogen), and 1 l of X-tremeGENE 9 DNA transfection reagent (Roche) was added to rescue mutated virus variants. The mixtures were incubated for 10 min at room temperature and added to subconfluent layers of EPC cells (1 ϫ 10 5 ) on a 24-well plate. The cells were incubated at 28°C for 5 h and then shifted to 15°C. The cell culture supernatants (passage 0) were clarified by centrifugation, 10-fold diluted, and inoculated onto a subconflu- Statistical analysis. A t test was used to calculate differences when relevant, and a P value of Ͻ0.05 was considered statistically significant.
RESULTS
Strain JF-09 is nonpathogenic to rainbow trout and highly pathogenic to olive flounder in an in vivo challenge. An experimental challenge of rainbow trout with WT JF-09 gave a cumulative percent mortality (CPM) of 7% by i.p. injection (10 5.5 TCID 50 per fish) and a CPM of 1% by immersion challenge (10 4.5 TCID 50 /ml of water) (Fig. 1A) , while DK-3592B gave a CPM of 73% (10 3.7 TCID 50 /ml of water, immersion infection; positive control). In contrast, we confirmed the virulence of WT JF-09 by an in vivo challenge of olive flounder, which gave a CPM of Ն80% (Fig. 1B) . Replication and induction of a CPE in primary trout cells can be used to differentiate between low-and high-virulence strains. DK-3592B and NO/650/07 infected, replicated, and caused a CPE in GECs, a pattern typical of high-virulence strains ( Fig. 2A to C) . 1p8 and JF-09 infected GECs ( Fig. 2A) but did not replicate (Fig. 2B) and did not cause a CPE or loss of viability in GECs (Fig. 2C) infected at an MOI of Յ10. Progeny of 1p8 and JF-09 were detected by IFAT in GECs ( Fig. 2A) , but at the same time, we found induction of Mx protein expression at 60 h postinfection ( Fig. 2A) , likely limiting the replication of the virus. We were also interested in assessing the impact of the MOIs (of all four strains) used to infect GECs, and MOIs of 15, 1.5, and 0.15 were tested and cell viability was monitored over a period of 96 h. At high MOIs (Ն1.5), DK-3592B and NO/650/07 induced a CPE earlier (Fig. 2C) , while for JF-09 and 1p8, there was no difference between MOIs of 0.15 and 1.5,which also did not differ from uninfected controls. At an MOI of 15, there was reduced viability, significantly lower than that of controls, from 3 days postinfection with JF-09 and 1p8 onward (Fig. 2C) . This shows that when given as a large infectious dose (single-cycle infection), low-virulence strains replicated and induced a CPE in GECs but the reduction in The CPM was 7% in the injected groups, which is not different from that in the uninfected group following an immersion challenge. DK-3592B was used as a positive control and gave a CPM of 73%. (B) Challenge of olive flounder with WT JF-09. Fish were injected i.m. with the WT JF-09 strain at the indicated titers per fish, and controls were injected with PBS. Onset of death occurred earlier in the high-challenge group. In both groups, the CPM was Ͼ80%.
viability was significantly less (P Ͻ 0.01) than that caused by DK-3592B and NV/650/07 (Fig. 2C) .
Nonvirulent and low-virulence strains of VHSV replicate less and are unable to translocate across polarized GECs (mimicking primary gill barriers) (15) . We therefore included a functional assay in which GECs were grown on filters and polarized and the different VHSV isolates were inoculated onto the apical side, i.e., on top of the insert filters (15) . DK-3592B and NO/650/07 were detected in the bottom samples, indicating translocation across the epithelium at 48 and 72 h postinfection. Detection was by culture on EPC cells confirmed by IFAT. In contrast, no 1p8 or JF-09 virus was detected in bottom wells over the observation period (Fig. 2D) , showing that these strains did not translocate across GECs in vitro. We also observed the extent to which the tight junctions of the cells were maintained; this was confirmed by measuring the TER (10 3 ⍀/cm 2 ) in parallel following DK-3592B infection, which was 3.74 ϫ 10 3 ⍀/cm 2 at 72 h postinfection (well above the 1.0 ϫ 10 3 ⍀/cm 2 threshold). Virulent rJF-09 was rescued from EPC cells. rJF-09 was rescued from transfected EPC cells, and the growth pattern and final virus titer were compared to those of WT JF-09 and found to be identical (Fig. 3A) . The full sequence of the rescued recombinant virus was also obtained, and the sequences were identical, except for position 91 in the NV protein (S91N, both polar amino acids). This had no impact on the growth pattern in permissive EPC cells (Fig. 3A) .
I1012F mutant JF-09 replicates and produces progeny in trout GECs. We then aligned the sequences of the four strains included in this study and found 13 positions that differed between high-and low-virulence strains (Table 4) . We selected eight positions (Fig. 3B ) in the G (one residue), NV (four residues), and L (three residues) proteins and generated mutated clones with one amino acid mutation per clone in the rJF-09 backbone. For the NV ORF, we also introduced a three-amino-acid en-block mutation, VSE to ILD (positions 55 to 57). The candidate proteins (G, NV, and L) were chosen because the G protein is a membrane protein involved in virus attachment and entry (25) and the NV protein has been shown to have an impact on antiapoptosis functions and virulence (23) . There are very few, if any, studies addressing to what extent the polymerase plays a role in the virulence of novirhabdoviruses, but it is well known that a single amino acid mutation in PB2 (polymerase B2 protein) of human influenza virus renders the virus able to replicate in chicken cells (26) . The various mutants (Table 4) were harvested from transfected EPC cells, all of the mutated variants grew in EPC cells and induced a CPE, and the harvested supernatants were used to infect GECs. We found that the I1012F mutant JF-09 virus infected GECs at MOIs ranging from 1 to 10 ( Fig. 3C and D) . None of the other mutated variants of rJF-09 were able to infect or replicate in GECs (Fig. 3C) . Furthermore, we assessed the replication of the I1012F mutant JF-09 virus by real-time RT-PCR and found a close-to-6-fold increase in virus replication over that of WT JF-09, while the replication level of the DK-3592B strain again was 50-fold higher (Fig. 3E) . We also compared the replication of WT JF-09 with that of the I1012F mutant isolate in a permissive cell line (EPC), and the titers obtained were similar and the growth curves of the two strains overlapped (Fig. 3F) . The entire genome of strain I1012F was also sequenced after culture in EPC cells and GECs, and the nucleotide sequences of the viruses obtained from the two cell lines were identical to that of the original clone, rJF-09, showing that no other compensatory mutations had occurred.
The I1012F mutant strain has an intermediate-virulence phenotype in trout GECs. As a next step, we measured the cell viability (cellular integrity) of infected GECs with a standard 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and found a significant drop in cell viability by 48 h and beyond (72 and 96 h postinfection; Fig. 4A ), where the I1012F mutant strain appeared as an intermediate-virulence variant between DK-3592B and WT JF-09. WT JF-09 was not different from the noninfected control. We also included GECs from different-size rainbow trout to account for the possible effect of the size of the donor fish (Fig. 4B) and found no effect. Further, rJF-09 and WT JF-09 had an amino acid difference in NV (S91N) and this had no impact on in vitro viru- Low virulence 1p8 lence to GECs; both were avirulent (Fig. 4B) . A CPE was observed, and virus protein (N) was detected in infected GECs at 48 h postinfection (Fig. 4C) . On the basis of these studies, we conclude that the I1012F mutant gains the abilities to infect trout GECs, produce viral progeny, and induce a CPE in infected cells. Finally, the entire genome of the I1012F mutant strain was also sequenced after passage in GEC cultures and the nucleotide sequence obtained was identical to that of the original I1012F mutant clone. We also aligned JF-09 with other NNS strains, with a particular focus on the CR. Position 1012 is located in the C-terminal part of CRIV, toward CRV (Table 5) .
DISCUSSION
The main finding of this study is that a single amino acid mutation (I1012F) of the viral polymerase renders an otherwise nonpathogenic marine isolate of VHSV able to infect, produce live progeny, and induce a CPE in primary cultures of trout gill cells. Exchange of amino acids of the G protein, the NV protein, or two other residues of the polymerase did not change the pathogenicity profile of the mutated virus strains. There are no previous publications addressing the importance of the polymerase for in vitro virulence of VHSV strains. WT JF-09 and 1p8 are both able to infect GECs but do not replicate and do not induce a CPE in cells infected at an MOI of Յ10 ( Fig. 2A to C) . Mutation of residue 1012 (I1012F) of the L protein enhanced the replication capacity of the polymerase, while two other point mutations had no such effect. The viral polymerase (L) protein is involved in many aspects of viral replication and transcription as a large RNA-dependent RNA polymerase (RdRp) complex component of VHSV, and here we also have an indication that the RdRp also plays a role in host specificity, with similarities to the viral heterotrimeric polymerase complex in influenza A virus (27) . The L protein of NNS RNA viruses has six CRs (CRI to CRVI) (28) . Following an alignment with other NNS viruses, some of which have relatively high levels of identity in the CRIV region, we found that position 1012 is located in the C-terminal region of CRIV, toward CRV. The RdRp activity maps to the CRIII region, which is also involved in polyadenylation, while CRV is involved in capping activities (29) (30) (31) . However, the function(s) of CRIV remains unclear, apart from the fact that it is a key structural component of the ring domain of the polymerase (30, 31) . It has been shown that point mutations (in the CRIV region) of Sendai virus and parainfluenza 3 virus render these viruses temperature sensitive (32, 33) . Further, mutation of codon 1321 of the L-encoding gene of human respiratory syncytial virus (hRSV) rendered the virus avirulent (34) . Additionally, deletion of codon 1313 also yielded an attenuated and temperature-sensitive vaccine candidate of hRSV (35) . We show here that a single point mutation (I1012F) in CRIV of VHSV increases virulence in nonpermissive cells. We have not explored if the mutation has an impact on transcription and/or replication, but a single mutation in CRIV (L992F) of Sendai virus resulted in better replication than transcription (33) . CRIV constitutes a part of the ring domain that creates a cage structure that is likely involved in the spatial coordination of template entry and product exit (28) . Mutations in this region of the L protein of NNS RNA viruses could thus potentially influence the functionality of viral transcription or replication, but additional studies are obviously needed to elucidate the mechanisms involved. Finally, I1012F mutant rJF-09 does not replicate to levels comparable to those of DK-3592B, but 5.6-fold higher replication levels than WT JF-09 at 48 h postinfection resulted in loss of GEC viability over 72 h of incubation and production of viral progeny. Thus, the I1012F variant has an intermediate virulence between those of highly virulent trout isolates and nonvirulent marine strains of VHSV.
The importance of the G protein in VHSV virulence has been subjected to a lot of research, motivated partly by the fact that the G protein is involved in virus attachment and entry (25) . However, it has not been possible to link particular residues or motifs of the G protein to virulence. In a recent study, it was shown that when the entire G protein of a nonvirulent marine VHSV isolates was used to create a VHSV G /IHNV NPMLNv hybrid (infectious hematopoietic necrosis virus [IHNV] backbone), this hybrid virus attained full virulence to rainbow trout (14) . We also could not identify any residue of the G protein that explains the differences in virulence between high-and low-virulence strains. All together, these findings strongly indicate that the G protein plays lesser of a role in the virulence of VHSV than has been discussed earlier.
We found that infected GECs show strong upregulation of Mx protein expression. At an MOI of Ͻ10, we did not see induction of a CPE and the virus could not be rescued from cell cultures. In contrast, when a high infectious dose level was used (MOI of 15), a CPE was observed but it was less extensive than that caused by the high-virulence strains. At such a high MOI, more than 99.95% of the cells will be infected with more than one virus particle (Poisson distribution), while at an MOI of 5, this fraction drops to 95.96%, and at an MOI of 0.15, only 13.93% of the cells (total) will be infected. This shows that low-pathogenicity strains rely on a high number of cells being infected with more than one virus particle for successful infection to take place. The fact that lowvirulence strains induce Mx protein expression (and also interferon I; not shown) is in contrast to what has been found in previous in vivo studies (36) , where low-virulence strains were not found to induce interferon and Mx responses in infected fish. These observations were obtained after an in vivo challenge of rainbow trout, and the authors also discussed the possibility that the nonvirulent strains did not pass across primary barriers (skin, gills, gut) and thus the lack of innate immune responses reflects a lack of infection and a lack of virus replication (36) .
Findings herein corroborate and extend results from a previous study showing that high-virulence strains of VHSV translo- (15, 19, 24) during the experimental period. Interestingly, the abilities to replicate and induce cytopathic responses in nonpolarized cultures of GECs correlate with translocation abilities. These findings are in contrast to what has been seen in a permanent rainbow trout GEC line (RTgill-W1), where the VHSV IVa and IVb strains, both of which are nonpathogenic to rainbow trout, were able to replicate, cause a CPE, and produce infectious progeny (37) , and no conclusion could be drawn with regard to pathogenicity on the basis of in vitro replication abilities, further substantiating the suitability of the GEC model.
